Philip D. Harvey, PhD | Psychiatrist.com

Academic Highlights

Improving Outcomes in Schizophrenia

May 4, 2021

What are some of the challenges you face in overcoming adherence issues and providing patient-centered care for people living with schizophrenia? Drs Harvey and Kane offer evidence and clinical...

Philip D. Harvey, John M. Kane

Educational Activity

Patient-Centered Care in Schizophrenia

March 23, 2021

Can a patient-centered approach to treatment be adopted for patients with schizophrenia? Can these patients take part in shared decision-making? Follow along as Dr Harvey shares his expertise.

Philip D. Harvey

Original Research

Cyberbullying and Adolescent Mental Health

January 14, 2020

Cyberbullying has received much mainstream media attention, but controversy exists regarding its prevalence. This study examined the prevalence of cyberbullying in adolescent psychiatric inpatients and its relation to potential...

Samantha Block Saltz, Maria Rozon, David L. Pogge, et al

Original Research

MIN-101 and Cognition in Schizophrenia Patients

May 15, 2018

The currently available dopamine-blocking antipsychotics haven' t been of much help with cognitive deficits in schizophrenia. This post hoc analysis of an RCT examines whether MIN-101, which combines sigma-2...

Richard S. E. Keefe, Philip D. Harvey, Anzalee Khan, et al

Letter to the Editor

Dr Kantrowitz and Colleagues Reply

October 26, 2016

Joshua T. Kantrowitz, Alice Medalia, Richard S. E. Keefe, et al

Educational Activity

Assessing Disability in Schizophrenia: Tools and Contributors

October 28, 2014

Philip D. Harvey

Clinical and Cost Implications of Treating Schizophrenia: Safety, Efficacy, Relapse Prevention, and Patient Outcomes

InfoPacks

Clinical and Cost Implications of Treating Schizophrenia: Safety, Efficacy, Relapse Prevention, and Patient Outcomes

August 26, 2014

John M. Kane, Christoph U. Correll, Philip D. Harvey, et al

DELETE Understanding the Lifetime Course of Schizophrenia

What Is the Evidence for Changes in Cognition and Functioning Over the Lifespan in Patients With Schizophrenia?

June 5, 2014

Philip D. Harvey

Supplement Article

Disability in Schizophrenia: Contributing Factors and Validated Assessments

February 21, 2014

Philip D. Harvey

Academic Highlights

Challenges and Solutions in Developing New Medications for Schizophrenia

October 15, 2010

Steven G. Potkin, Adrian Preda, Amir H. Kalali, et al

Article

Effects of Lithium on Cognitive Performance: A Meta-Analysis

August 11, 2009

Aliza P. Wingo, Thomas S. Wingo, Philip D. Harvey, et al

Educational Activity

Managing Cognitive Deficits and Functioning in Patients With Schizophrenia

September 17, 2007

Philip D. Harvey

1 2 »